Lista de obras -

A single cycle of rituximab for the treatment of severe pemphigus.

artículo científico publicado en 2007

Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases

artículo científico publicado en 2015

Allergological approach to drug hypersensitivity reactions

artículo científico publicado en 2008

Autoimmune bullous disorders

artículo científico publicado en 2006

Autoimmune bullous skin diseases. Part 1: Clinical manifestations ⬇️

artículo científico publicado el 1 de octubre de 2011

Autoimmune bullous skin diseases. Part 2: diagnosis and therapy ⬇️

artículo científico publicado el 1 de noviembre de 2011

Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris

artículo científico publicado en 2013

B-cell-directed therapy for inflammatory skin diseases

artículo científico publicado en 2009

CD3-positive B cells: a storage-dependent phenomenon

artículo científico publicado en 2014

Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.

artículo científico publicado en 2008

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

artículo científico publicado en 2008

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.

artículo científico publicado en 2011

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

artículo científico publicado en 2014

Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA.

artículo científico publicado en 2005

Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis.

artículo científico publicado en 2017

Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases

artículo científico publicado en 2011

Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles

artículo científico publicado en 2003

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.

artículo científico publicado en 2016

Europäische Leitlinien (S1) für die Anwendung von hochdosierten intravenösen Immunglobulinen in der Dermatologie

artículo científico publicado en 2017

Flotillins directly interact with γ-catenin and regulate epithelial cell-cell adhesion

artículo científico publicado en 2013

IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion

artículo científico publicado en 2011

Immunoadsorption in pemphigus

artículo científico publicado en 2006

Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus

artículo científico publicado en 2016

Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris

artículo científico publicado en 2015

Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus

artículo científico publicado en 2007

Loss of flotillin expression results in weakened desmosomal adhesion and Pemphigus vulgaris-like localisation of desmoglein-3 in human keratinocytes

artículo científico publicado en 2016

Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus

artículo científico publicado en 2017

Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.

artículo científico publicado en 2017

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology

artículo científico publicado en 2016

Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy

artículo científico publicado en 2007

Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.

artículo científico publicado en 2014

Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.

artículo científico publicado en 2012

Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study

artículo científico publicado en 2008

Population-Specific Association between a Polymorphic Variant in ST18, Encoding a Pro-Apoptotic Molecule, and Pemphigus Vulgaris

Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases

artículo científico publicado en 2012

Proteome dynamics in biobanked horse peripheral blood derived lymphocytes (PBL) with induced autoimmune uveitis.

artículo científico publicado en 2017

Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases

artículo científico publicado en 2007

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

artículo científico publicado en 2008

Research in practice: Treatment of autoimmune bullous disorders

artículo científico publicado en 2009

Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid

artículo científico publicado en 2009

S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid

artículo científico publicado en 2015

S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid

artículo científico publicado en 2015

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

artículo científico publicado en 2011

Severity score indexes for blistering diseases ⬇️

artículo científico publicado el 1 de enero de 2012

Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions.

artículo científico publicado en 2017

T cell control in autoimmune bullous skin disorders

artículo científico publicado en 2006

T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin

artículo científico publicado en 2003

Type I regulatory T cells in autoimmunity and inflammatory diseases

artículo científico publicado en 2006

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)

scientific article published on 24 August 2020

Use of high-dose immunoglobulins in dermatology

artículo científico publicado en 2009

Lista de obras de

A single cycle of rituximab for the treatment of severe pemphigus.

Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases

Allergological approach to drug hypersensitivity reactions

Autoimmune bullous disorders

Autoimmune bullous skin diseases. Part 1: Clinical manifestations ⬇️

Autoimmune bullous skin diseases. Part 2: diagnosis and therapy ⬇️

Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris

B-cell-directed therapy for inflammatory skin diseases

CD3-positive B cells: a storage-dependent phenomenon

Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy.

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.

Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.

Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA.

Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis.

Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases

Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.

Europäische Leitlinien (S1) für die Anwendung von hochdosierten intravenösen Immunglobulinen in der Dermatologie

Flotillins directly interact with γ-catenin and regulate epithelial cell-cell adhesion

IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion

Immunoadsorption in pemphigus

Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus

Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris

Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus

Loss of flotillin expression results in weakened desmosomal adhesion and Pemphigus vulgaris-like localisation of desmoglein-3 in human keratinocytes

Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus

Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016.

Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology

Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy

Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.

Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.

Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study

Population-Specific Association between a Polymorphic Variant in ST18, Encoding a Pro-Apoptotic Molecule, and Pemphigus Vulgaris

Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases

Proteome dynamics in biobanked horse peripheral blood derived lymphocytes (PBL) with induced autoimmune uveitis.

Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

Research in practice: Treatment of autoimmune bullous disorders

Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid

S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid

S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

Severity score indexes for blistering diseases ⬇️

Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions.

T cell control in autoimmune bullous skin disorders

T-cellular autoimmunity against desmogleins in pemphigus, an autoantibody-mediated bullous disorder of the skin

Type I regulatory T cells in autoimmunity and inflammatory diseases

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)

Use of high-dose immunoglobulins in dermatology